These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16628299)

  • 21. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial.
    Pernica JM; Harman S; Kam AJ; Carciumaru R; Vanniyasingam T; Crawford T; Dalgleish D; Khan S; Slinger RS; Fulford M; Main C; Smieja M; Thabane L; Loeb M
    JAMA Pediatr; 2021 May; 175(5):475-482. PubMed ID: 33683325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011.
    Moyes J; Cohen C; Pretorius M; Groome M; von Gottberg A; Wolter N; Walaza S; Haffejee S; Chhagan M; Naby F; Cohen AL; Tempia S; Kahn K; Dawood H; Venter M; Madhi SA;
    J Infect Dis; 2013 Dec; 208 Suppl 3():S217-26. PubMed ID: 24265481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
    Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
    Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.
    Awasthi S; Agarwal G; Kabra SK; Singhi S; Kulkarni M; More V; Niswade A; Pillai RM; Luke R; Srivastava NM; Suresh S; Verghese VP; Raghupathy P; Lodha R; Walter SD
    PLoS One; 2008 Apr; 3(4):e1991. PubMed ID: 18431478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
    Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
    BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
    Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
    Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and correlates of treatment failure among Kenyan children hospitalised with severe community-acquired pneumonia: a prospective study of the clinical effectiveness of WHO pneumonia case management guidelines.
    Agweyu A; Kibore M; Digolo L; Kosgei C; Maina V; Mugane S; Muma S; Wachira J; Waiyego M; Maleche-Obimbo E
    Trop Med Int Health; 2014 Nov; 19(11):1310-20. PubMed ID: 25130866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The early natural history of vertically transmitted HIV-1 infection in African children from Durban, South Africa.
    Bobat R; Moodley D; Coutsoudis A; Coovadia H; Gouws E
    Ann Trop Paediatr; 1998 Sep; 18(3):187-96. PubMed ID: 9924555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and outcome of first line treatment failure among under-five children with community acquired severe pneumonia at Bugando Medical Centre, Mwanza, Tanzania: A prospective cohort study.
    Muro RP; Masoza TS; Kasanga G; Kayange N; Kidenya BR
    PLoS One; 2020; 15(12):e0243636. PubMed ID: 33306722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
    Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
    BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children.
    Madhi SA; Petersen K; Madhi A; Khoosal M; Klugman KP
    Clin Infect Dis; 2000 Jul; 31(1):170-6. PubMed ID: 10913417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of human immunodeficiency virus infection on episodes of diarrhea among children in South Africa.
    Johnson S; Hendson W; Crewe-Brown H; Dini L; Frean J; Perovic O; Vardas E
    Pediatr Infect Dis J; 2000 Oct; 19(10):972-9. PubMed ID: 11055599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children.
    Kalyesubula I; Musoke-Mudido P; Marum L; Bagenda D; Aceng E; Ndugwa C; Olness K
    Pediatr Infect Dis J; 1997 Sep; 16(9):876-81. PubMed ID: 9306483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Trial of Amoxicillin for Pneumonia in Pakistan.
    Jehan F; Nisar I; Kerai S; Balouch B; Brown N; Rahman N; Rizvi A; Shafiq Y; Zaidi AKM
    N Engl J Med; 2020 Jul; 383(1):24-34. PubMed ID: 32609980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study.
    Miller TL; Easley KA; Zhang W; Orav EJ; Bier DM; Luder E; Ting A; Shearer WT; Vargas JH; Lipshultz SE; ;
    Pediatrics; 2001 Dec; 108(6):1287-96. PubMed ID: 11731650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
    Das RR; Singh M
    PLoS One; 2013; 8(6):e66232. PubMed ID: 23825532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia.
    Yoshimine H; Oishi K; Mubiru F; Nalwoga H; Takahashi H; Amano H; Ombasi P; Watanabe K; Joloba M; Aisu T; Ahmed K; Shimada M; Mugerwa R; Nagatake T
    Am J Trop Med Hyg; 2001; 64(3-4):172-7. PubMed ID: 11442214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment failure among Kenyan children with severe pneumonia--a cohort study.
    Webb C; Ngama M; Ngatia A; Shebbe M; Morpeth S; Mwarumba S; Bett A; Nokes DJ; Seale AC; Kazungu S; Munywoki P; Hammitt LL; Scott JA; Berkley JA
    Pediatr Infect Dis J; 2012 Sep; 31(9):e152-7. PubMed ID: 22692700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.
    EMPIC Study Group
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 34987033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.